7.3301

0.00% 0.000100

Moolec Science Sa (MLEC)

Overview News Price History Discussions Forecast

Moolec Science Sa stock is traded at $7.3301, with a volume of 1,719. It is up +0.00% in the last 24 hours and up +1.10% over the past month. Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.

Previous Close:

$7.33

Open:

$7.3301

24h Volume:

1,719

Relative Volume:

0.02

Market Cap:

$5.32M

Revenue:

$7.83M

Net Income/Loss:

$-8.28M

P/E Ratio:

-0.4343

EPS:

-16.8761

Net Cash Flow:

$-6.85M

1W Performance:

-7.97%

1M Performance:

+1.10%

6M Performance:

+74.11%

1Y Performance:

-91.53%

1-Day Range:

$7.3301

1-Week Range:

$6.79

$8.00

52-Week Range:

$3.0765

$82.65

Moolec Science Sa Stock (MLEC) Company Profile

Name

Moolec Science Sa

Sector

Healthcare (1096)

Industry

Biotechnology (616)

Phone

Address

Employee

Twitter

Next Earnings Date

2026-04-15

Latest SEC Filings

MLEC's Discussions on Twitter

Compare MLEC vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MLEC Moolec Science Sa	7.3301	5.32M	7.83M	-8.28M	-6.85M	-16.88
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Moolec Science Sa Stock (MLEC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-27-23	Initiated	ROTH MKM	Buy

Moolec Science Sa Stock (MLEC) Latest News

Jul 10, 2026

12 Consumer Staples Stocks Moving In Friday's Intraday Session - Sahm

Jul 10, 2026

MLEC Q2 2025 Earnings: Narrower-than-expected loss amid pre‑revenue stageNew Analyst Coverage - dars.gov.et

Jul 10, 2026

Jul 08, 2026

Price to sales forward of Moolec Science SA – NASDAQ:MLECW - TradingView

Jul 08, 2026

Price to book forward of Moolec Science SA – NASDAQ:MLECW - TradingView

Jul 08, 2026

Enterprise value to EBITDA forward of Moolec Science SA – NASDAQ:MLECW - TradingView

Jul 08, 2026

Jul 05, 2026

Why Did This Nano-Cap Food Stock More Than Double In Value Today? - Stocktwits

Jul 05, 2026

Jul 02, 2026

Moolec Science Company Profile & Introduction - Moomoo

Jul 02, 2026

Jul 01, 2026

MLEC Q2 2025 Earnings: Narrower Net Loss Beats Estimates as Pre-Revenue Company Advances ScienceEarnings Growth Analysis - dars.gov.et

Jul 01, 2026

Jun 29, 2026

Moolec Science (MLEC) Surges Over 6%: Potential Breakout or Short-Term Rally?Butterfly Setup - dars.gov.et

Jun 29, 2026

Jun 27, 2026

Moolec Science (MLEC) Edges Lower Near Key Resistance LevelSocial Sentiment - dars.gov.et

Jun 27, 2026

Jun 26, 2026

Enterprise value to EBITDA forward of Moolec Science SA – NASDAQ:MLEC - TradingView

Jun 26, 2026

MLEC Q2 2025 Earnings: Narrower-Than-Expected Loss as Pre-Revenue Biotech AdvancesEBITDA Estimate Trend - dars.gov.et

Jun 25, 2026

Jun 23, 2026